Evidence map›Paper›PMID 35089562›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2022

Applications of Cell-Free Synthesized Membrane Protein Precipitates.

Julija Mezhyrova, Karsten Mörs, Clemens Glaubitz, Volker Dötsch, Frank Bernhard

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Julija MezhyrovaCentre for Biomolecular Magnetic Resonance, Institute for Biophysical Chemistry, Goethe-University , Frankfurt/Main, Germany.
Karsten MörsCentre for Biomolecular Magnetic Resonance, Institute for Biophysical Chemistry, Goethe-University , Frankfurt/Main, Germany.
Clemens GlaubitzCentre for Biomolecular Magnetic Resonance, Institute for Biophysical Chemistry, Goethe-University , Frankfurt/Main, Germany.
Volker DötschCentre for Biomolecular Magnetic Resonance, Institute for Biophysical Chemistry, Goethe-University , Frankfurt/Main, Germany.
Frank BernhardCentre for Biomolecular Magnetic Resonance, Institute for Biophysical Chemistry, Goethe-University , Frankfurt/Main, Germany. fbern@bpc.uni-frankfurt.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cell-free protein expression systems are new core platforms for membrane protein synthesis. Expression in the presence of supplied artificial hydrophobic environments such as nanomembranes or micelles allows the co-translational solubilization and folding of membrane proteins. In the absence of hydrophobic compounds, the synthesized membrane proteins quantitatively precipitate, while frequently still retaining a significant part of folded structural elements. This so-called precipitate-forming cell-free (P-CF) expression mode is a very effective and reliable approach for numerous applications. Even from complex membrane proteins such as G-protein coupled receptors or large transporters, significant amounts of such precipitates can be synthesized within few hours. The precipitates can be solubilized in detergents or reconstituted into membranes for subsequent structural or functional analysis. Harsh denaturation and refolding procedures as known from the treatment of bacterial inclusion bodies are usually not required.This strategy is particularly interesting for applications requiring large amounts of membrane protein or fast access to a sample. It is further an excellent tool for the production of membrane protein antigens suitable for antibody generation. The purification of the precipitates in downstream processing is streamlined as only few proteins from the cell-free lysate may co-precipitate with the synthesized membrane protein. For most applications, a one-step affinity chromatography by taking advantage of small purification tags attached to the membrane protein target is sufficient. We give an overview on current applications of P-CF precipitates and describe the underlying techniques in detail. We furthermore provide protocols for the successful crystallization and NMR analysis of P-CF synthesized membrane proteins exemplified with the diacylglycerol kinase (DAGK). In addition, we describe the functional characterization of a P-CF synthesized large eukaryotic transporter.

Indexed as

Membrane ProteinsProtein FoldingCell-Free SystemDetergentsEscherichia coliProtein Processing, Post-TranslationalDetergentsMembrane ProteinsCell-free protein expressionCell-free protein precipitatesDiacylglycerol kinase (DAGK)Inclusion bodiesMembrane proteinsOrganic cation transporterP-CF modeSolid-state NMR

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.